The University of Chicago Header Logo

Connection

Peter O'Donnell to Immunoconjugates

Back to Details
This is a "connection" page, showing publications Peter O'Donnell has written about Immunoconjugates.
Peter O'Donnell
Connection Strength
1.431
Immunoconjugates
  1. In Reply. Oncologist. 2022 10 01; 27(10):e827-e828.
    View in: PubMed
    Score: 0.729
  2. Management of Dermatologic Events Associated With the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotin. Oncologist. 2022 03 11; 27(3):e223-e232.
    View in: PubMed
    Score: 0.702
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.